Literature DB >> 25408433

Effectiveness and Safety of Sleeve Gastrectomy, Gastric Bypass, and Adjustable Gastric Banding in Morbidly Obese Patients: a Multicenter, Retrospective, Matched Cohort Study.

Kemal Dogan1, Ralph P M Gadiot, Edo O Aarts, Bark Betzel, Cees J H M van Laarhoven, Laser U Biter, Guido H H Mannaerts, Theo J Aufenacker, Ignace M C Janssen, Frits J Berends.   

Abstract

BACKGROUND: Laparoscopic adjustable gastric band (LAGB), laparoscopic sleeve gastrectomy (LSG), and laparoscopic Roux-en-Y gastric bypass (LRYGB) are the most performed procedures worldwide (92 %) nowadays. However, comparative clinical trials are scarce in literature. The objective of this study was to compare the effectiveness and safety of the three most performed bariatric procedures.
METHODS: A multicenter, retrospective, matched cohort study was conducted. Patients were eligible for analysis when a primary procedure was performed between 2007 and 2010 in one of the two specialized bariatric centers. Primary outcome was weight loss, expressed in the percentage excess weight loss (%EWL). Secondary outcome parameters are hospital stay, complication rate, and revisional surgery.
RESULTS: In total, 735 patients, 245 in each group, were included for analysis. The groups were comparable for age and gender after matching. Mean postoperative follow-up was 3.1 ± 1.2 years. LAGB patients showed less %EWL compared to LSG and LRYGB at all postoperative follow-up visits. LRYGB showed a %EWL of 71 ± 20 % compared to LSG (76 ± 23 %; p=0.008) after 1-year follow-up; thereafter, no significant difference was observed. After 3 years of follow-up, LAGB showed a higher complication rate compared to LSG and LRYGB (p<0.05). Revisional surgery after LAGB was needed in 21 %, while 9 % of the LSG underwent conversion to RYGB.
CONCLUSIONS: LRYGB is a safe and effective treatment in morbid obese patients with good long-term outcomes. LSG seems to be an appropriate alternative as a definitive procedure, in terms of weight reduction and complication rate. LAGB is inferior to both LRYGB and LSG.

Entities:  

Mesh:

Year:  2015        PMID: 25408433     DOI: 10.1007/s11695-014-1503-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  56 in total

1.  A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs.

Authors:  Ninh T Nguyen; Johnathan A Slone; Xuan-Mai T Nguyen; Jaimee S Hartman; David B Hoyt
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

Review 2.  A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding.

Authors:  Juan Victor A Franco; Pablo Adrian Ruiz; Mariano Palermo; Michel Gagner
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

3.  A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates.

Authors:  M Suter; J M Calmes; A Paroz; V Giusti
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

4.  Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.

Authors:  Gianfranco Silecchia; Cristian Boru; Alessandro Pecchia; Mario Rizzello; Giovanni Casella; Frida Leonetti; Nicola Basso
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

5.  Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.

Authors:  David Nocca; Fabre Guillaume; Patrick Noel; Marie Christine Picot; Rajesh Aggarwal; Moez El Kamel; Roxanne Schaub; Charles de Seguin de Hons; Eric Renard; Jean Michel Fabre
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

6.  Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial.

Authors:  Luigi Angrisani; Michele Lorenzo; Vincenzo Borrelli
Journal:  Surg Obes Relat Dis       Date:  2007-02-27       Impact factor: 4.734

7.  Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure?

Authors:  Ajay Chopra; Edward Chao; Yana Etkin; Lynn Merklinger; Jayne Lieb; Harry Delany
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

8.  Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial.

Authors:  Luigi Angrisani; Pier Paolo Cutolo; Giampaolo Formisano; Gabriella Nosso; Giuliana Vitolo
Journal:  Surg Obes Relat Dis       Date:  2013-01-31       Impact factor: 4.734

Review 9.  Surgical treatment of obesity.

Authors:  Mariëlle J F Bult; Thijs van Dalen; Alex F Muller
Journal:  Eur J Endocrinol       Date:  2008-02       Impact factor: 6.664

10.  Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)-a prospective study.

Authors:  Simone Gehrer; Beatrice Kern; Thomas Peters; Caroline Christoffel-Courtin; Ralph Peterli
Journal:  Obes Surg       Date:  2010-01-26       Impact factor: 4.129

View more
  28 in total

1.  Comparison of Outcomes Between Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Lebanese Bariatric Surgical Practice.

Authors:  Hanaa Dakour Aridi; Georges Khazen; Bassem Y Safadi
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  Comparative Efficacy and Safety of Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy: A Meta-analysis.

Authors:  Yu Tang; Shanhong Tang; Sanyuan Hu
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

3.  Laparoscopic sleeve gastrectomy is an independent predictor of poor follow-up and reaching ≤ 40% excess body weight loss at 1, 2, and 3 years after bariatric surgery.

Authors:  Anahita Jalilvand; Alecia Blaszczak; Jane Dewire; Andrew Detty; Bradley Needleman; Sabrena Noria
Journal:  Surg Endosc       Date:  2019-07-29       Impact factor: 4.584

4.  Trends in Utilization and Relative Complication Rates of Bariatric Procedures.

Authors:  Ann Y Chung; Paula D Strassle; Francisco Schlottmann; Marco G Patti; Meredith C Duke; Timothy M Farrell
Journal:  J Gastrointest Surg       Date:  2019-04-22       Impact factor: 3.452

Review 5.  Comparison of Laparoscopic Sleeve Gastrectomy and Laparoscopic Greater Curvature Plication Regarding Efficacy and Safety: a Meta-Analysis.

Authors:  Qinghuang Ye; Yan Chen; Xiaoli Zhan; Yuedong Wang; Jinhui Zhu
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

6.  Clinical Outcomes of Sleeve Gastrectomy Versus Roux-En-Y Gastric Bypass After Failed Adjustable Gastric Banding.

Authors:  Chang Wu; Fu-Gang Wang; Wen-Mao Yan; Ming Yan; Mao-Min Song
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

7.  Inflammatory Bowel Disease Is Not a Contraindication for Bariatric Surgery.

Authors:  Stephanie Aelfers; Ignace M C Janssen; Edo O Aarts; Carolijn Smids; Marcel J Groenen; Frits J Berends
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

Review 8.  Curbing Obesity from One Generation to Another: the Effects of Bariatric Surgery on the In Utero Environment and Beyond.

Authors:  Redin A Spann; Bernadette E Grayson
Journal:  Reprod Sci       Date:  2020-06-23       Impact factor: 3.060

9.  Impact of Weight Loss Surgery on Esophageal Physiology.

Authors:  Rishi D Naik; Yash A Choksi; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-12

10.  Long-Term Weight Loss and Metabolic Syndrome Remission after Bariatric Surgery: The Effect of Sex, Age, Metabolic Parameters and Surgical Technique - A 4-Year Follow-Up Study.

Authors:  Vanessa Guerreiro; João Sérgio Neves; Daniela Salazar; Maria João Ferreira; Sofia Castro Oliveira; Pedro Souteiro; Jorge Pedro; Daniela Magalhães; Ana Varela; Sandra Belo; Paula Freitas; Davide Carvalho
Journal:  Obes Facts       Date:  2019-11-20       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.